Biocon’s fundraising is viewed positively to manage debt. Expert Nischal Maheshwari is optimistic about Biocon’s future, expecting earlier investments to yield returns. He also favors contract development and manufacturing firms like Laurus Labs. Maheshwari sees potential in banking, metals, and power sectors, particularly execution-focused players in power.
FIIs dump Indian stocks for 10th straight week as markets slide: Is the worst over or more pain ahead?
The Nifty 50 declined in all four sessions of the holiday-shortened week, hitting an intraweek low of 22,372 on Friday before closing 2.4% lower at